Oncological and perioperative outcomes of robot-assisted radical cystectomy: a real-world cohort study emulating a target trial
Journal of Robotic Surgery · 2026
DOI: 10.1007/s11701-026-03975-5 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Robotic Surgery, 2026. Verfasst von Minseok Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics and Data Science, Chung-Ang University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Cystectomy, Urinary Bladder Neoplasms. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chung-Ang University Medical Center.
Abstract (Originalsprache)
We tried to evaluate the comparative effectiveness of robot-assisted radical cystectomy (RARC) and open radical cystectomy (ORC) using nationwide real-world data within a target trial framework. Nationwide claims were used to identify individuals with bladder cancer who received transurethral resection during 2007-2020. Surgical strategies were defined according to receipt of RARC or ORC during a 1-year grace period. Cloning, censoring, and weighting were used to align treatment strategies from a common time zero and account for treatment-selection and immortal-time biases. The primary outcome was overall survival, with perioperative outcomes and healthcare expenditures examined secondarily. Among 45,595 eligible individuals, surgery within the grace period consisted of ORC in 3,681 and RARC in 358. Weighted analysis showed no evidence of a difference in overall survival (HR, 1.18; 95% CI, 0.96-1.45). Postoperative hospitalization was shorter with RARC than with ORC (18.4 vs. 22.5 days; P < 0.001), and transfusion was required in 51.1% and 70.6%, respectively (P < 0.001). RARC was associated with lower covered healthcare expenditure between surgery and discharge (P = 0.030), but cumulative expenditures at 2 and 5 years were comparable between groups. In this nationwide target trial emulation, assignment to RARC did not materially alter overall survival relative to ORC but yielded more favorable perioperative findings. These findings support RARC as a surgical alternative to ORC while highlighting the value of target trial emulation for evaluating real-world surgical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Statistics and Data Science, Chung-Ang University, Seoul, Republic of Korea.
- Department of Applied Statistics, Chung-Ang University, Seoul, Republic of Korea.
- Department of Pharmacy and Biohealth Industry, Chung-Ang University, Seoul, Korea, Republic of.
- Department of Urology, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
- Department of Urology, Cho Ray Hospital, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
- Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea. urosyc@cau.ac.kr.
Förderung
- Chung-Ang University Medical Center
Zitieren
APA
Kim, M., Lee, J., Shin, Y. S., Nguyen, T. T., & Choi, S. Y. (2026). Oncological and perioperative outcomes of robot-assisted radical cystectomy: a real-world cohort study emulating a target trial. Journal of Robotic Surgery. https://doi.org/10.1007/s11701-026-03975-5
Vancouver
Kim M, Lee J, Shin YS, Nguyen TT, Choi SY. Oncological and perioperative outcomes of robot-assisted radical cystectomy: a real-world cohort study emulating a target trial. Journal of Robotic Surgery. 2026. doi:10.1007/s11701-026-03975-5
BibTeX
@article{Kim2026,
author = {Kim, Minseok and Lee, Jooyoung and Shin, Yu Seob and Nguyen, Tuan Thanh and Choi, Se Young},
title = {Oncological and perioperative outcomes of robot-assisted radical cystectomy: a real-world cohort study emulating a target trial},
journal = {Journal of Robotic Surgery},
year = {2026},
doi = {10.1007/s11701-026-03975-5}
}
EUVIMED